Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma.
Jinfang LiuJun XuBinlin LuoJian TangZuoqiong HouZhechen ZhuLingjun ZhuGang YaoChujun LiPublished in: Cancers (2022)
We constructed an immune prognosis model using RBM38-related immune DEGs that may help evaluate melanoma patient prognosis and immunotherapy modalities.